title: [Updated treatment of primary pulmonary hypertension -- the role of endothelin receptor antagonists].
authors.forename: J L
authors.initials: JL
authors.lastname: Callejas Rubio
authors.forename: N
authors.initials: N
authors.lastname: Ortego Centeno
authors.forename: F
authors.initials: F
authors.lastname: Navarro Pelayo
authors.forename: I
authors.initials: I
authors.lastname: Vallejo Rodríguez
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007555:Isoxazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D007555:Isoxazoles; D013449:Sulfonamides; D013876:Thiophenes; C106276:sitaxsentan; D000077300:Bosentan
vernacular_title: Actualización en el tratamiento de la hipertensión pulmonar primaria: papel de los antagonistas de receptores de endotelinas.